News
4317 posts · page 18 of 180
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, a turnaround from last year's loss, driven by Truenat test-kit demand.
Indian AI Cancer Care Platform Gains Recognition at BRICS Summit
iOncology.ai, developed by AIIMS and C-DAC, is spotlighted in a BRICS health journal for its innovative approach to cancer care.
Waystar Considers Sale Amid Declining Valuation, Engages Evercore
Waystar explores a potential sale, engaging Evercore as adviser, amidst a 24% share price drop.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
Federal initiatives deploy A.I. for therapy and prescriptions, sparking safety debates.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating to acquire Sofie Biosciences for $1 billion, potentially expanding its diagnostics division.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing last year's loss, bolstered by Truenat test-kit sales.
Indian AI Platform iOncology.ai Showcased in BRICS Health Journal
iOncology.ai, an AI-driven cancer care platform by AIIMS and C-DAC, gains recognition in the BRICS Health Journal.
Waystar Considers Strategic Options Amid Market Challenges
Healthcare tech firm Waystar, advised by Evercore, explores sale options as stock value dips.
U.S. Pushes A.I. in Healthcare Amid Safety and Investment Concerns
The Trump administration's push for A.I. in healthcare sparks safety and investor influence worries.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a potential $1 billion acquisition of Sofie Biosciences to enhance its pharmaceutical diagnostics segment.
Digital Monitoring Reveals Stability in Chronic Pain During Tertiary Care
Digital tools show stable pain levels in chronic non-cancer patients during tertiary care, offering insights for future treatments.
Assaults on Doctors Spark Protests, Heighten Security Concerns in Telangana
Recent attacks on doctors in Telangana have ignited protests and raised urgent calls for improved hospital security measures.
Indonesia Revamps Hospital System with AIIB Support
Indonesia partners with AIIB to upgrade teaching hospitals, enhancing healthcare quality and system efficiency.
Bradford Royal Infirmary Launches Revamped Renal Dialysis Unit
Bradford Royal Infirmary has unveiled its newly refurbished renal dialysis unit, enhancing patient care and treatment capacity.
Molbio Diagnostics Achieves Rs 52.7 Cr Profit in Q1 After IPO
Molbio Diagnostics reported a Rs 52.7 crore profit in Q1, driven by robust Truenat test-kit sales, following its recent IPO.
Indian AI Platform iOncology.ai Featured in BRICS Health Journal
iOncology.ai, developed by AIIMS and C-DAC, gains spotlight in BRICS Health Journal for its potential to enhance cancer care.
Waystar Considers Sale Amidst Falling Market Value, Sources Reveal
Waystar is exploring a potential sale, with investment bank Evercore advising the process, sources say.
Trump Admin Pushes A.I. in Healthcare Amid Safety Concerns
The Trump administration is advancing A.I. in healthcare, sparking safety debates as A.I. agents begin offering therapy and prescriptions.
Florida Couple's IVF Mix-Up Reveals Different Biological Father
A Florida couple discovers an IVF error after DNA tests reveal the husband is not the biological father of their newborn.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer scan chemicals, according to reports.
Molbio Diagnostics Reports Rs 52.7 Crore Q1 Profit Post-IPO
Molbio Diagnostics sees a Rs 52.7 crore profit in Q1, reversing last year's loss, fueled by Truenat test-kit sales.
India's AI Cancer Platform iOncology.ai Gains Global Spotlight at BRICS Summit
iOncology.ai, an AI cancer care platform from India, featured in BRICS Health Journal, aims to enhance early detection and treatment.
Waystar Considers Sale Amidst Market Challenges, Sources Reveal
Waystar is exploring strategic options, including a potential sale, following a decline in market value.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
The Trump administration is advancing A.I. in medical care, sparking debates over safety and investor influence.